Fulcrum Therapeutics, Inc.
FULC
$3.74
$0.030.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 318.84M | 333.32M | 352.31M | 200.65M | 214.11M |
| Total Receivables | 2.03M | 1.78M | 1.07M | 934.00K | 1.33M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.08M | 3.58M | 4.10M | 4.28M | 3.93M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 900.00K | -- | -- | -- | -- |
| Total Current Assets | 322.85M | 338.67M | 357.48M | 205.86M | 219.37M |
|
|
|||||
| Total Current Assets | 322.85M | 338.67M | 357.48M | 205.86M | 219.37M |
| Net Property, Plant & Equipment | 0.00 | 6.35M | 7.07M | 7.79M | 8.25M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.10M | 1.75M | 1.74M | 1.21M | 1.22M |
| Total Assets | 323.95M | 346.77M | 366.28M | 214.86M | 228.84M |
|
|
|||||
| Total Accounts Payable | 3.43M | 2.45M | 1.59M | 2.86M | 1.75M |
| Total Accrued Expenses | 3.73M | 4.65M | 8.79M | 6.19M | 4.77M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.52M | 2.46M | 2.40M | 2.35M | 2.29M |
| Total Finance Division Other Current Liabilities | 624.00K | 308.00K | 258.00K | 236.00K | 173.00K |
| Total Other Current Liabilities | 624.00K | 308.00K | 258.00K | 236.00K | 173.00K |
| Total Current Liabilities | 10.30M | 9.86M | 13.05M | 11.63M | 8.99M |
|
|
|||||
| Total Current Liabilities | 10.30M | 9.86M | 13.05M | 11.63M | 8.99M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.76M | 3.41M | 4.04M | 4.66M | 5.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 197.00K | 197.00K | 197.00K | 197.00K | 197.00K |
| Total Liabilities | 13.26M | 13.47M | 17.28M | 16.49M | 14.46M |
|
|
|||||
| Common Stock & APIC | 950.61M | 946.99M | 943.10M | 772.07M | 768.65M |
| Retained Earnings | -639.35M | -613.17M | -594.28M | -573.94M | -554.35M |
| Treasury Stock & Other | -567.00K | -513.00K | 174.00K | 241.00K | 82.00K |
| Total Common Equity | 310.70M | 333.30M | 349.00M | 198.37M | 214.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 310.70M | 333.30M | 349.00M | 198.37M | 214.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 310.70M | 333.30M | 349.00M | 198.37M | 214.38M |
|
|
|||||